BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35103883)

  • 1. A study of the prognostic value of long non-coding RNA CASC15 in human solid tumors utilizing The Cancer Genome Atlas (TCGA) datasets and a meta-analysis.
    Chen W; Qian W; Nie J; Dai M
    Clin Exp Med; 2023 Feb; 23(1):65-78. PubMed ID: 35103883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of long non-coding RNA H19 in various cancers: A meta-analysis based on 15 studies with 1584 patients and the Cancer Genome Atlas data.
    Yu H; Li S; Wu SX; Huang S; Li S; Ye L
    Medicine (Baltimore); 2020 Jan; 99(2):e18533. PubMed ID: 31914026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA CASC2 in solid tumors: A meta-analysis.
    Liang C; Zhang J; Ge H; Xu Y; Ren S; Yue C; Li G; Wu J
    Clin Chim Acta; 2018 Nov; 486():357-368. PubMed ID: 30144439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets.
    Shu Q; Liu X; Yang J; Mou T; Xie F
    Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
    Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
    BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
    Wang J; Zhong P; Hua H
    Technol Cancer Res Treat; 2021; 20():15330338211004915. PubMed ID: 33906548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
    Zhong P; Hua H; Chen S; Zhu Z; Xie F
    Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and Clinicopathological Significance of Long Non-Coding RNA BLACAT1 in Cancer: An Updated Meta-Analysis and TCGA Data Review.
    Wu T; Wang Q; Ding M; Zhu X; Wu Y
    Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA CRNDE as a potential prognostic biomarker in solid tumors: A meta-analysis.
    Liang C; Zhang B; Ge H; Xu Y; Li G; Wu J
    Clin Chim Acta; 2018 Jun; 481():99-107. PubMed ID: 29501692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
    Zhang S; Qiu D; Xie X; Shen Y
    BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XIST as a valuable biomarker for prognosis and clinical parameters in diverse tumors: a comprehensive meta- and bioinformatics analysis.
    Zhang MJ; Yan Z; Qin J; Luo TH; Yang B
    Neoplasma; 2022 Sep; 69(5):1217-1227. PubMed ID: 35900315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical prognostic value of long noncoding RNA HAND2-AS1 in cancer patients: A study based on meta-analysis and TCGA data (PRISMA).
    Yan Z; Lu J; Xu X; You Y; Xu J; Xu T
    Medicine (Baltimore); 2022 Sep; 101(39):e30789. PubMed ID: 36181101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of long non-coding RNA five prime to XIST in various cancers.
    Zhou J; Chen J; Chen Z; Wu G; Zhou Z; Wu T; Wang W; Luo Y; Liu T
    BMC Cancer; 2022 Jan; 22(1):61. PubMed ID: 35027040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
    Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
    BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA CYTOR in cancer: A TCGA data review.
    Liang J; Wei X; Liu Z; Cao D; Tang Y; Zou Z; Zhou C; Lu Y
    Clin Chim Acta; 2018 Aug; 483():227-233. PubMed ID: 29750962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles.
    Zhang Y; Liang C; Zhang Y; Wang Z; Li R; Wei Z; Guo J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and prognostic value of long noncoding RNA SNHG7 in cancers: a meta-analysis and bioinformatics.
    Wang J; Du S; Wang C; Zhu Z; Xie B; Zhang B
    Aging (Albany NY); 2021 Oct; 13(20):23796-23809. PubMed ID: 34714775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.